HRT Financial’s BioNTech BNTX Stock Holding History

HRT Financial’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-37,500	Closed	-$3.57M	–	3832
2025 Q4	$3.57M	Buy	+37,500	New	+$3.78M	0.01%	954
2022 Q4	–	Sell	-1,500	Closed	-$202K	–	2491
2022 Q3	$202K	Buy	+1,500	New	+$229K	﹤0.01%	2205
2022 Q2	–	Sell	-6,600	Closed	-$1.13M	–	2964
2022 Q1	$1.13M	Buy	+6,600	New	+$1.11M	0.01%	943
2021 Q4	–	Sell	-1,800	Closed	-$491K	–	3221
2021 Q3	$491K	Buy	+1,800	New	+$572K	﹤0.01%	2009

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

HRT Financial's BNTX Position: Q2 2026 in Review

HRT Financial opened a new position in BioNTech (BNTX) in Q2 2026: 58,648 shares worth $5.46M. The stake represents 0.01% of the portfolio and ranks #1101 among its holdings. This is a return to the name: HRT Financial previously reported a position in BNTX as recently as Q4 2025.

HRT Financial first reported a position in BNTX in Q2 2022 and has held it in 7 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

HRT Financial held 58,648 shares of BioNTech worth $5.46M as of Q2 2026.
BioNTech was a new HRT Financial position in Q2 2026.
BioNTech made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1101 holding.
HRT Financial first reported a position in BioNTech in Q2 2022 and has held it in 7 quarters since.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.